Clinical Trial Update: Phase II Studies Of Donepezil And Ginkgo Biloba In Irradiated Brain Tumor [Phase 2]

View source ↗

Summary

Phase II study evaluating donepezil and Ginkgo Biloba for irradiated brain tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain and Central Nervous System Tumors
• Radiation Toxicity

Drugs mentioned

• Donepezil (donepezil)
• Ginkgo biloba (Ginkgo biloba)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Brain and Central Nervous System Tumors, Radiation Toxicity | Phase 2 | Status: COMPLETED